An overview of circulating cell-free nucleic acids in diagnosis and prognosis of triple-negative breast cancer
D Tierno, G Grassi, F Zanconati, M Bortul… - International Journal of …, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer due to its
molecular heterogeneity and poor clinical outcomes. Analysis of circulating cell-free tumor …
molecular heterogeneity and poor clinical outcomes. Analysis of circulating cell-free tumor …
A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology
A Kramer, C Rubio‐Alarcón… - Molecular …, 2023 - Wiley Online Library
Circulating tumor DNA (ctDNA) detection has multiple promising applications in oncology,
but the road toward implementation in clinical practice is unclear. We aimed to support the …
but the road toward implementation in clinical practice is unclear. We aimed to support the …
Circulating tumor DNA in identifying resistant sub-clones post EGFR blockade: implications for EGFR rechallenge
A Chennamadhavuni, PM Kasi - Frontiers in Oncology, 2022 - frontiersin.org
For patients with metastatic RAS/RAF wild-type refractory colorectal cancer, the question of
anti-EGFR therapy rechallenge often comes up after initial use. However, not all patients …
anti-EGFR therapy rechallenge often comes up after initial use. However, not all patients …